1994
DOI: 10.1016/0003-2670(94)80061-8
|View full text |Cite
|
Sign up to set email alerts
|

Binding of homologous and heterologous isoluminol- and enzyme-labelled progesterone conjugates to monoclonal antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…Mitsuma et al [16] have demonstrated an increase in the sensitivity of progesterone EIA that uses bridge heterology Influence of Length Linker on DHEA-3-HS-Antibody 13 in the label. Boever et al [17] have demonstrated an increase in the sensitivity of progesterone assay that uses different sites for label and immunogen preparation. Similarly, Shrivastav et al [24] have demonstrated an increase in the sensitivity of DHEA assay that uses different sites for label and immunogen preparation.…”
Section: Precisionmentioning
confidence: 98%
See 2 more Smart Citations
“…Mitsuma et al [16] have demonstrated an increase in the sensitivity of progesterone EIA that uses bridge heterology Influence of Length Linker on DHEA-3-HS-Antibody 13 in the label. Boever et al [17] have demonstrated an increase in the sensitivity of progesterone assay that uses different sites for label and immunogen preparation. Similarly, Shrivastav et al [24] have demonstrated an increase in the sensitivity of DHEA assay that uses different sites for label and immunogen preparation.…”
Section: Precisionmentioning
confidence: 98%
“…[35] The incorporation of spacer arms might have resulted in minimization of the conventional bridge recognition effects, decrease in the influence of local environment, and overcoming steric constraints between the two high molecular weight proteins, i.e., antibody and label. [15][16][17] The specificities of the antibodies obtained depend partly on the nature of the steroid link to the protein carrier, in particular the position on the steroid nucleus at which the linker is attached, since this determines the orientation of the steroid in the antibody combining site. For a ligand such as a steroid, the binding site is likely to consist of a hydrophobic cavity or pocket in which most of the ligand surface becomes buried.…”
Section: Precisionmentioning
confidence: 99%
See 1 more Smart Citation